Earlier intervention in the management of hypercholesterolemia: what are we waiting for?

Explore this paper's citation graph

Summary

The thesis advanced here is that the authors are initiating treatment of hypercholesterolemia (and other risk factors) too late in life, and starting treatment at, for example, age 30 years instead of age 60 years might very well prevent not just 30% of events, as in the 5-year statin trials, but perhaps as many as 60%.

Type
article
Published
2010-08-17
Cited by
50
References
19
Access
Open access

Keywords

Medicine, Intervention (counseling), Familial hypercholesterolemia, Gerontology, Intensive care medicine

References

Cited by

Related papers